A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch

Secukinumab as biological treatment for psoriatic arthritis in real clinical practice José A. Pinto Tasende, Francisco J. Maceiras Pan, José A. Mosquera Martínez, Luis Fernández Dominguez, Blanca Correa Rey, Carlos García Porrúa

Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis Julio Casasola-Vargas, Diana Flores-Alvarado, Luis H. Silveira, Sandra Sicsik-Ayala, Greta Reyes-Cordero, Guadalupe Villanueva Quintero, Mario Amaya Guerra, Sara G. Reyes Orozco, Beatriz E. Zazueta Montiel, Roberto Hernández-Paz, Angélica Mendoza-Fuentes, Ana G. Bernard-Medina, Alejandra López Rodriguez, Rosa E. Barbosa Cobos, Rubén Burgos-Vargas, César Pacheco-Tena